HCM
KERX

Highlander Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Highlander Capital Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-20,000
Closed -$275K – 876
2014
Q3 		$275K Buy
+20,000
New +$306K 0.26% 100

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Highlander Capital Management's KERX Position: Q4 2014 in Review

Highlander Capital Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2014, closing a stake of 20,000 shares — an estimated $275K sold.

Highlander Capital Management first reported a position in KERX in Q3 2014 and held it in 1 quarter. The position peaked at $275K in Q3 2014. 147 funds tracked by Wall St. Rank hold KERX as of Q4 2014.

  • Highlander Capital Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Highlander Capital Management sold 20,000 Keryx Biopharmaceuticals Inc shares in Q4 2014, an estimated $275K.
  • Highlander Capital Management first reported a position in Keryx Biopharmaceuticals Inc in Q3 2014 and held it in 1 quarter.
  • Highlander Capital Management's Keryx Biopharmaceuticals Inc position peaked at $275K in Q3 2014.
  • 147 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2014.

Based on Highlander Capital Management's 13F filing for Q4 2014, filed 11 Feb 2015.